topotecan has been researched along with gdc 0449 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Chaturvedi, NK; Coulter, DW; Joshi, SS; McGuire, TR; McIntyre, EM; Sharp, JG; Shukla, A | 1 |
2 other study(ies) available for topotecan and gdc 0449
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Improved therapy for neuroblastoma using a combination approach: superior efficacy with vismodegib and topotecan.
Topics: Anilides; Animals; Apoptosis; Cell Proliferation; Drug Therapy, Combination; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neuroblastoma; Pyridines; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |